Singapore markets closed
Straits Times Index
3,265.95 +1.42 (+0.04%) S&P 500
5,188.60 +0.93 (+0.02%) Dow
39,025.56 -30.83 (-0.08%) Nasdaq
16,311.19 +8.43 (+0.05%) Bitcoin USD
61,347.54 -663.30 (-1.07%) CMC Crypto 200
1,325.29 +25.19 (+1.94%)
LLY Sep 2024 400.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:26AM EDT. Market open.
Loading interactive chart…
- Thomson Reuters StreetEvents
Q1 2024 Amphastar Pharmaceuticals Inc Earnings Call
Q1 2024 Amphastar Pharmaceuticals Inc Earnings Call
- Zacks
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- Benzinga
What About Eli Lilly's Drug For Early Alzheimer's? FDA Panel To Discuss Next Month
Tuesday, the FDA said it would convene an in-person meeting of the Peripheral and Central Nervous System Drugs Advisory Committee on Monday, June 10, 2024, to discuss Eli Lilly and Co’s (NYSE:LLY) donanemab for early symptomatic Alzheimer’s disease. The open public hearing portion of the meeting will be conducted virtually. The Phase 3 study submitted as part of this application, TRAILBLAZER-ALZ 2, is a double-blind, placebo-controlled study to evaluate the safety and efficacy of donanemab in pa
© 2024 Yahoo. All rights reserved.